John Wiley & Sons B (WLYB)
Official siteCOMMUNICATION SERVICES • PUBLISHING • NYSE
Market Cap: $2.54B
Last updated: Nov 17, 2026 at 10:22 AM ET
John Wiley & Sons B (WLYB) Earnings: Report Dates and Results
John Wiley & Sons B (WLYB) is expected to report earnings on Dec 3, 2026. In the quarter ended Jul 31, 2026, John Wiley & Sons B reported EPS of $0.44. It beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
WLYB has an expected report date of Dec 3, 2026. No consensus estimate is on file yet for the quarter ended Oct 31, 2026.
WLYB Earnings Call
The latest WLYB earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 38 quarters below that had an estimate, WLYB beat 9, missed 12 and matched 17. Revenue for the quarter ended Jul 31, 2026 was $386.36M, down 2.6% from $396.80M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | $0.44 | N/A | N/A | N/A | N/A | -10.2% | N/A | N/A | Sep 3, 2026 | $386.36M |
| Apr 30, 2026 | $2.61 | N/A | N/A | N/A | N/A | +108.5% | N/A | N/A | Jun 16, 2026 | $447.94M |
| Jan 31, 2026 | $0.56 | $0.81 | N/A | -30.42% | Miss | N/A | N/A | N/A | Mar 5, 2026 | $410.04M |
| Oct 31, 2025 | $0.84 | $0.88 | N/A | -4.68% | Miss | +13.7% | N/A | N/A | Dec 4, 2025 | $421.75M |
| Jul 31, 2025 | $0.49 | $0.47 | N/A | +4.26% | Beat | N/A | N/A | 0 up, 0 down | Sep 4, 2025 | $396.80M |
| Apr 30, 2025 | $1.25 | $1.31 | N/A | -4.55% | Miss | +174.0% | N/A | 0 up, 0 down | Jun 17, 2025 | $442.58M |
| Jan 31, 2025 | -$0.43 | $0.65 | N/A | -165.46% | Miss | N/A | N/A | 0 up, 0 down | Mar 6, 2025 | $404.63M |
| Oct 31, 2024 | $0.74 | $1.07 | N/A | -31.07% | Miss | +1.0% | N/A | 0 up, 0 down | Dec 5, 2024 | $426.60M |
| Jul 31, 2024 | -$0.03 | $0.55 | N/A | -104.80% | Miss | -109.8% | N/A | N/A | Sep 5, 2024 | $403.81M |
| Apr 30, 2024 | $0.46 | $0.88 | N/A | -48.14% | Miss | -68.5% | N/A | N/A | Jun 13, 2024 | $468.46M |
| Jan 31, 2024 | -$2.08 | $0.54 | N/A | -484.74% | Miss | -344.4% | N/A | N/A | Mar 7, 2024 | $460.70M |
| Oct 31, 2023 | $0.73 | $0.56 | N/A | +30.36% | Beat | -39.2% | N/A | N/A | Dec 6, 2023 | $492.81M |
| Jul 31, 2023 | $0.27 | $0.45 | N/A | -40.00% | Miss | -25.0% | N/A | N/A | Sep 7, 2023 | $451.01M |
| Apr 30, 2023 | $1.45 | $0.99 | N/A | +46.46% | Beat | +34.3% | N/A | N/A | Jun 15, 2023 | $526.13M |
| Jan 31, 2023 | $0.85 | $0.85 | N/A | 0.00% | In line | -10.5% | N/A | N/A | Mar 9, 2023 | $491.37M |
| Oct 31, 2022 | $1.20 | $1.20 | N/A | 0.00% | In line | -7.0% | N/A | N/A | Dec 7, 2022 | $514.84M |
| Jul 31, 2022 | $0.36 | $0.36 | N/A | 0.00% | In line | -33.3% | N/A | N/A | Sep 7, 2022 | $487.57M |
| Apr 30, 2022 | $1.08 | $1.08 | N/A | 0.00% | In line | +28.6% | N/A | N/A | Jun 15, 2022 | $545.65M |
| Jan 31, 2022 | $0.95 | $0.95 | N/A | 0.00% | In line | +39.7% | N/A | N/A | Mar 9, 2022 | $515.88M |
| Oct 31, 2021 | $1.29 | $1.29 | N/A | 0.00% | In line | +29.0% | N/A | N/A | Dec 8, 2021 | $533.00M |
| Jul 31, 2021 | $0.54 | $0.54 | N/A | 0.00% | In line | +28.6% | N/A | N/A | Sep 3, 2021 | $488.39M |
| Apr 30, 2021 | $0.84 | $0.84 | N/A | 0.00% | In line | +27.3% | N/A | N/A | Jul 6, 2021 | $536.25M |
| Jan 31, 2021 | $0.68 | $0.68 | N/A | 0.00% | In line | 0.0% | N/A | N/A | Mar 5, 2021 | $482.91M |
| Oct 31, 2020 | $1.00 | $1.00 | N/A | 0.00% | In line | +17.6% | N/A | N/A | Dec 10, 2020 | $491.01M |
| Jul 31, 2020 | $0.42 | $0.42 | N/A | 0.00% | In line | +100.0% | N/A | N/A | Sep 4, 2020 | $431.33M |
| Apr 30, 2020 | $0.66 | $0.66 | N/A | 0.00% | In line | -37.1% | N/A | N/A | Jun 26, 2020 | $474.62M |
| Jan 31, 2020 | $0.68 | $0.68 | N/A | 0.00% | In line | +11.5% | N/A | N/A | Mar 6, 2020 | $467.13M |
| Oct 31, 2019 | $0.85 | $0.85 | N/A | 0.00% | In line | -4.5% | N/A | N/A | Dec 5, 2019 | $466.20M |
| Jul 31, 2019 | $0.21 | $0.21 | N/A | 0.00% | In line | -51.2% | N/A | N/A | Sep 6, 2019 | $423.53M |
| Apr 30, 2019 | $1.05 | $1.05 | N/A | 0.00% | In line | +11.7% | N/A | N/A | Jul 1, 2019 | $491.18M |
| Jan 31, 2019 | $0.61 | $0.78 | N/A | -21.79% | Miss | -29.9% | N/A | N/A | Mar 8, 2019 | $449.37M |
| Oct 31, 2018 | $0.89 | $0.89 | N/A | 0.00% | In line | -13.6% | N/A | N/A | Dec 6, 2018 | $448.62M |
| Jul 31, 2018 | $0.43 | $0.50 | N/A | -14.00% | Miss | -27.1% | N/A | N/A | Sep 7, 2018 | $410.90M |
| Apr 30, 2018 | $0.94 | $0.79 | N/A | +18.99% | Beat | +14.6% | N/A | N/A | Jun 29, 2018 | $477.25M |
| Jan 31, 2018 | $0.87 | $0.82 | N/A | +6.10% | Beat | -5.4% | N/A | N/A | Mar 6, 2018 | $455.68M |
| Oct 31, 2017 | $1.03 | $0.82 | N/A | +25.61% | Beat | +35.5% | N/A | N/A | Dec 8, 2017 | $455.68M |
| Jul 31, 2017 | $0.59 | $0.62 | N/A | -4.84% | Miss | +13.5% | N/A | N/A | Sep 7, 2017 | $411.44M |
| Apr 30, 2017 | $0.82 | $0.59 | N/A | +38.98% | Beat | +22.4% | N/A | N/A | Jun 29, 2017 | $452.20M |
| Jan 31, 2017 | $0.92 | $0.78 | N/A | +17.95% | Beat | +37.3% | N/A | N/A | Mar 7, 2017 | $452.20M |
| Oct 31, 2016 | $0.76 | $0.66 | N/A | +15.15% | Beat | -2.6% | N/A | N/A | Dec 12, 2016 | $436.46M |
Annual EPS
EPS for the fiscal year ended Apr 30, 2026 was $4.50, up 192.9% from the year before. It was $3.02 for the year ended Apr 30, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Apr 30, 2026 | $4.50 | +192.9% |
| Apr 30, 2025 | $1.54 | N/A |
| Apr 30, 2024 | -$0.62 | -116.1% |
| Apr 30, 2023 | $3.86 | N/A |
| Apr 30, 2022 | $3.86 | +31.3% |
| Apr 30, 2021 | $2.94 | +22.5% |
| Apr 30, 2020 | $2.40 | -19.5% |
| Apr 30, 2019 | $2.98 | -13.1% |
| Apr 30, 2018 | $3.43 | +13.6% |
| Apr 30, 2017 | $3.02 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,500 words across 6 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 6,489 | 6 | |
| 2026Q2 | Jun 30, 2026 | 5,895 | 6 | |
| 2026Q1 | Mar 31, 2026 | 7,274 | 6 | |
| 2025Q4 | Dec 31, 2025 | 6,295 | 6 | |
| 2025Q3 | Sep 30, 2025 | 6,634 | 7 | |
| 2025Q2 | Jun 30, 2025 | 5,707 | 6 | |
| 2025Q1 | Mar 31, 2025 | 5,823 | 6 | |
| 2024Q4 | Dec 31, 2024 | 6,792 | 7 |
2026Q3 Earnings Call
Opening remarks
Brian Campbell Vice President, Investor Relations Good morning, everyone. With me today are Matthew Kissner, President and CEO; Craig Albright, Executive Vice President and CFO; and Jay Flynn, Executive Vice President and General Manager of Research and Learning. Our comments and responses reflect management views as of today and will include forward-looking statements. Actual results may differ materially from those statements. The company does not undertake any obligation to update them to reflect subsequent events. Also, John Wiley & Sons, Inc. provides non-GAAP measures as a supplement to evaluate underlying operating profitability and performance trends. These measures do not have standardized meanings prescribed by U.S. GAAP and, therefore, may not be comparable to similar measures used by other companies, nor should they be viewed as alternatives to measures under GAAP. We will refer to non-GAAP metrics on the call, and variances are on a year-over-year basis. We will exclude divested assets and the impact of currency. Additional information is included in our filings with the SEC. A copy of this presentation and transcript will be available at investors.wiley.com. I will now turn the call over to Matthew Kissner.
Matthew Kissner President and CEO Thank you, Brian. Hello, everyone, and welcome to our fiscal Q3 earnings update. Before I get to our performance and progress, I want to acknowledge the market's concerns amid AI fears across the market. The fact is we do not share those same fears. Quite the opposite. We could not be more confident in our position in the AI economy given our proprietary content advantage, wide moat in peer review research, and unparalleled partnership ecosystem. The ongoing opportunity is twofold. AI is expected to greatly accelerate scientific discovery and research publishing output, and our enriched data and AI solutions are foundational for corporate R&D, AI models, and applications. I will discuss this in more detail later in our call. The third quarter was fully in line with our stated expectations. Revenue performance was impacted by an unfavorable comparable in research, which we called out in the second quarter, and soft market conditions in learning. We continue to accelerate in all major areas of focus. Research publishing continues to outpace the market with global output up 11%, revenue up 4% excluding AI revenue, and steady growth in our multiyear renewals. In AI and data services, we announced new leadership, launched our clinical outcome assessments partnership with IQVIA, and after quarter close, executed a strategic multiyear partnership with Open Evidence to deliver trusted research at the point of medical care. We also secured a new AI model training customer, our first outside the U.S., and realized $7,000,000 of AI revenue. We are rapidly advancing our technology transformation initiatives with the announcement of a multiyear managed services partnership with Virtusa.
Frequently Asked Questions About WLYB
When is John Wiley & Sons B's next earnings date?
John Wiley & Sons B's next earnings report is expected for Dec 3, 2026.
How often does WLYB beat earnings estimates?
John Wiley & Sons B beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate, with an average surprise of -48.11%.
WLYB pages: Overview, Dividends, Earnings, Financials, Valuation, Competitors